Health Care: Drugs

Lexicon Pharmaceuticals Inc (LXRX: NASDAQ)

$8.05 0.17 | 2.16%
06/30/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 22.85M 2.22M 1.09M 1.85M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 22.85M 2.22M 1.09M 1.85M
Selling, General, and Administrative Expenses 19.41M 17.12M 17.04M 17.35M
Research & Development 89.28M 89.68M 82.57M 91.83M
Operating Income before D & A (EBITDA) -85.84M -104.58M -98.53M -107.33M
Depreciation & Amortization 2.03M 2.86M 4.19M 4.89M
Interest Income 2.26M 157.00K 213.00K 255.00K
Other Income - Net 0.00 59.00K -9.78M -6.61M
Special Income / Charges -14.53M 2.21M 0.00 0.00
Total Income Before Interest Expenses (EBIT) -100.14M -105.02M -112.29M -118.57M
Interest Expense 2.25M 1.97M 2.11M 2.53M
Pre-Tax Income -102.39M -106.99M -114.40M -121.10M
Income Taxes -70.00K 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -100.29M -104.13M -110.21M -116.22M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -100.29M -104.13M -110.21M -116.22M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -100.29M -104.13M -110.21M -116.22M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-85.76M -106.34M -110.21M -116.22M
Preferred Dividends
Net Income Available To Common -100.29M -104.13M -110.21M -116.22M
Basic EPS from Continuing Ops. -1.31 -1.42 -1.58 -2.39
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.31 -1.42 -1.58 -2.39
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) -0.02 0.02 -0.03 0.01
Basic EPS, Total -1.33 -1.40 -1.61 -2.38
Basic Normalized Net Income/Share -1.12 -1.45 -1.58 -2.39
EPS fr Continuing Ops. -1.31 -1.42 -1.58 -2.39
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.31 -1.42 -1.58 -2.39
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.02 0.02 -0.03 0.01
EPS, Total -1.33 -1.40 -1.61 -2.38
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.12 -1.45 -1.58 -2.39
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with LXRX

Latest LXRX Headlines from TheStreet

More Financial News for LXRX

Press Releases for LXRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter